Dr. Feldmesser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
178 East 85th Street
4th Floor
New York, NY 10028Phone+1 212-434-3427Fax+1 212-434-6275
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1993 - 1997
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1986 - 1989
- Duke University School of MedicineClass of 1986
Certifications & Licensure
- NY State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 317 citationsCryptococcus neoformans Is a Facultative Intracellular Pathogen in Murine Pulmonary InfectionMarta Feldmesser, Yvonne Kress, Phyllis Novikoff, Arturo Casadevall
Infection and Immunity. 2000-07-01 - 149 citationsAspergillus fumigatus: Principles of pathogenesis and host defenseTobias M. Hohl, Marta Feldmesser
Eukaryotic Cell. 2007-11-01 - 112 citationsEffect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.Marta Feldmesser, Arturo Casadevall
Journal of Immunology. 1997-01-15
Press Mentions
- West Nile Disease Is in All Mainland U.S. States: What to KnowSeptember 26th, 2021
- Questions Parents Have About CoronavirusMarch 13th, 2020
- U.S. States Struggle to Expand Coronavirus Testing Despite Federal PushMarch 11th, 2020
- Join now to see all
Grant Support
- Protein Biomarkers For Invasive Aspergillosis DiagnosticsNational Institute Of Allergy And Infectious Diseases2012
- Protein Biomarkers For Invasive Aspergillosis DiagnosticsNational Institute Of Allergy And Infectious Diseases2010–2011
- Monoclonal Antibodies To Inhibit Aspergillus GerminationNational Institute Of Allergy And Infectious Diseases2006–2010
- Aspergillosis: Engineering Antibody For DiagnosisNational Institute Of Allergy And Infectious Diseases2005–2006
- Monoclonal Antibodies For Invasive AspergillosisNational Institute Of Allergy And Infectious Diseases2002–2003
- Antibody Action Mechanism Against Cryptococcus NeoformanNational Institute Of Allergy And Infectious Diseases1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: